Last updated: Nov 20, 2026, 12:00 AM

Arbutus Biopharma Corp Exchange (NASDAQ, USD)

ABUS

4.02
-0.04 (-0.97%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-8.54%
3 year return (CAGR)
29.36%
5 year return (CAGR)
3.24%
10 year return (CAGR)
3.81%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
623.83M
Price/Sales
3.43
Ent value
619.95M
Price/Book
2.41
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
4.08
PEG
-
Forward P/E
-
EPS growth
-26.95%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open4.12
Daily high4.16
Daily low4.05
Daily Volume2.44M
All-time high30.94
1y analyst estimate5.47
Beta0.81
EPS (TTM)0.78
Dividend per share0.00
Ex-div date-
Next earnings date26 Feb 2026

Ready to capitalize on Arbutus Biopharma Corp's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
ABUSS&P500
Current price drop from All-time high-87.01%-11.46%
Highest price drop-97.19%-56.47%
Date of highest drop9 Oct 20199 Mar 2009
Avg drop from high-75.70%-10.64%
Avg time to new high144 days12 days
Max time to new high3195 days1805 days